Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opening Session Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Opportunities to Optimize Cancer Policies Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Jan
28
Today In Oncology
Organ-Sparing Pelvic Radiotherapy May Reduce Female Sexual Toxicity
Associations Found Between Air Pollutants and Lung Cancer Subtypes
Multiple Myeloma FDA Approves Daratumumab and Hyaluronidase-fihj in Combination With VRd
Is Long-Term PPI Use Associated With Increased Gastric Cancer Risk
Chemoradiation Plus Atezolizumab in Limited-Stage Small Cell Lung Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo